No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates

Abstract

The risk of ONJ in these patients must be considered so low that the patients with indications for treatment should be treated and get the chance to experience the well-documented beneficial effect for children with severe OI.